Benson M. George

Affiliations: 
2014-2018 Stem Cell Stanford University School of Medicine, Palo Alto, CA, United States 
Google:
"Benson George"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Pedram K, Shon DJ, Tender GS, et al. (2023) Design of a mucin-selective protease for targeted degradation of cancer-associated mucins. Nature Biotechnology
Buckley MT, Sun ED, George BM, et al. (2022) Cell-type-specific aging clocks to quantify aging and rejuvenation in neurogenic regions of the brain. Nature Aging. 3: 121-137
Zaro BW, Noh JJ, Mascetti VL, et al. (2020) Proteomic analysis of young and old mouse hematopoietic stem cells and their progenitors reveals post-transcriptional regulation in stem cells. Elife. 9
Ji AL, Rubin AJ, Thrane K, et al. (2020) Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma. Cell
Gulati GS, Zukowska M, Noh JJ, et al. (2019) Neogenin-1 distinguishes between myeloid-biased and balanced mouse long-term hematopoietic stem cells. Proceedings of the National Academy of Sciences of the United States of America
Tsai JM, Shoham M, Fernhoff NB, et al. (2019) Neutrophil and monocyte kinetics play critical roles in mouse peritoneal adhesion formation. Blood Advances. 3: 2713-2721
Dulken BW, Buckley MT, Navarro Negredo P, et al. (2019) Single-cell analysis reveals T cell infiltration in old neurogenic niches. Nature
George BM, Kao KS, Kwon HS, et al. (2019) Antibody Conditioning Enables MHC-Mismatched Hematopoietic Stem Cell Transplants and Organ Graft Tolerance. Cell Stem Cell
Sockolosky JT, Trotta E, Parisi G, et al. (2018) Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes. Science (New York, N.Y.). 359: 1037-1042
Barkal AA, Weiskopf K, Kao KS, et al. (2018) Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy. Nature Immunology. 19: 76-84
See more...